A better understanding of how microenvironmental factors regulate cancer dormancy is needed for development of new therapeutic strategies to control metastatic recurrence and disease progression. Modeling cancer dormancy using engineered, in vitro platforms is necessary for investigation under well-defined and wellcontrolled microenvironments. We present methods and protocols to fabricate, characterize, and implement engineered hydrogels with well-defined biochemical and physical properties for control over breast cancer cell phenotype in three-dimensional (3D) culture. Changes in hydrogel adhesivity, crosslink density, and degradability induce a range of phenotypic behaviors in breast cancer cells including: (1) high growth, (2) moderate growth, (3) single cell, restricted survival dormancy, and (4) balanced dormancy. We describe a method of classifying hydrogel formulations that support each of these phenotypic states. We also describe a method to phenotypically switch cancer cells from single cell dormancy to high growth by dynamically modulating ligand density, thereby recapitulating reactivation and metastatic recurrence. 
Method details

Introduction
A major challenge underlying treatment of metastatic cancer is the presence of dormant tumor cells in various organs; at the primary site and in secondary sites post dissemination [1, 2] . These dormant cell populations are difficult to detect and treat owing to their low proliferation, quiescent nature, and high degree of resistance against standard chemotherapeutics. Investigating the molecular mechanisms underlying tumor dormancy is necessary to develop new therapeutic strategies to eliminate dormant populations in a targeted, specific manner. Unfortunately, in vivo models, owing to their physiological complexity and poor control of experimental conditions, are not optimal for investigating the dormancy phenomenon [3] . Hence, in vitro platforms with well-defined, user-controlled properties are useful for systematic investigation of microenvironmental factors that regulate dormancy in a reproducible, higher-throughput fashion.
The microenvironment of the primary tumor as well as secondary metastatic sites is an important regulator of the phenotypic plasticity exhibited by tumor cells and influences the switch between tumor dormancy and metastatic reactivation [4, 5] . In particular, specific physical (stiffness, pore size) and biochemical (adhesivity, degradability) properties of the extracellular matrix (ECM) have been posited to influence the phenotypic states of cancer cells and thereby induce dormancy [3, 6] . Hence systematic tuning of these properties in engineered synthetic matrices and adopting a materialsdirected approach in controlling cancer cell states may provide an avenue for investigating tumor dormancy in vitro.
Toward this goal, we developed a set of sixteen, poly(ethylene glycol) (PEG)-based hydrogel formulations with well-defined physical and biochemical properties that can be used for encapsulation and three-dimensional (3D) culture of cancer cells for extended time periods ($75 days) that induce various phenotypic states, including tumor dormancy, via tuning of the hydrogel properties [7, 8] . We present methods to fabricate these hydrogels, characterize their properties (ligand density, elasticity, swelling, degradability, diffusivity, and pore size), evaluate cellular metrics (viability, proliferation, early apoptosis, metabolic activity, cell/cluster morphology) corresponding to various phenotypic states (high growth, moderate growth, single cell restricted survival dormancy, and balanced dormancy), classify hydrogel formulations based on the phenotype induced, and reactivate single, dormant tumor cells into a highly proliferative state.
Hydrogel stock solution preparation
This protocol describes the methods for preparation of stock solutions that constitute the PEGbased hydrogel precursor.
Materials/equipment
-Phosphate-buffered saline (PBS, sterile) -PEG-PQ-PEG macromer (PEG-PQ, 3.4 kDa) (For synthesis protocol, see Refs. [7, 9] ) -PEG-RGDS macromer (3.4 kDa) (For synthesis protocol, see Refs. [7, 10, 11] ) -Lithium acyl phosphinate (LAP) (For synthesis protocol, see Refs. [11, 12] ) -N-vinyl pyrrolidinone (NVP, Sigma-Aldrich)
1 Prepare PEG-PQ stock in PBS (20 % w/v) (200 mg/mL or 10 mg/50 mL).
2 Prepare PEG-RGDS stock in PBS (20 mM) (68 mg/mL or 6.8 mg/100 mL).
3 Prepare LAP stock in PBS (30 mg/mL or 3 mg/100 mL).
Note: LAP powder may need to be sonicated for 15-20 min and vortexed thoroughly for complete dissolution. Note: Protect all solutions containing LAP from light using aluminum foil to prevent unwanted photopolymerization and store at 4 C for subsequent use.
4 Prepare NVP stock in PBS (10 mL/mL or 10 mL + 990 mL PBS).
5 Prepare final precursor solution with PEG-PQ = 5 % w/v, PEG-RGDS = 0, 1, 5, or 10 mM, LAP = 3 mg/mL and NVP = 0, 0.5, 1, or 2 mL/mL and adjust with PBS (Table 1) . Mix all components thoroughly to ensure uniform mixing.
Cell preparation
This protocol describes the method of preparation of cancer cell suspension used subsequently for hydrogel encapsulation. 4 Aspirate media to obtain cell pellet, resuspend cell pellet in 1 mL media. 5 Count cells in hemocytometer.
Note: Cell encapsulation can be performed in the range of 1-50*10 6 cells/mL, 10*10 6 cells/mL is recommended. At this density, for 100 mL of polymer precursor, 1*10 6 cells are needed.
Cell encapsulation in hydrogels
This protocol describes the method for encapsulation of cancer cells within PEG-based hydrogels with well-defined composition via UV-initiated photocrosslinking and subsequent 3D culture. Note: Try to remove all the media as remaining media can dilute the polymer precursor solution and inhibit crosslinking. Minimize the time that cells are in direct contact with the liquid polymer precursor, usually 4À5 min is long enough. Mix the cell pellet quickly and uniformly in the precursor solution.
5 Pipette 3 mL droplets of cell-laden precursor solution onto the hydrophobic Parafilm surface ($15-20 droplets) (See Fig. 1 Ref. [7] ) and crosslink under the UV lamp (Blak-Ray flood UV lamp, wavelength: 365 nM, intensity: 10 mW/cm 2 , height of UV lamp from Parafilm surface: 8 in.) for 1 min (Fig. 1) . Note: Pipetting of hydrogel droplets must be completed as rapidly as possible to prevent cells from settling to the bottom of the droplets. Note: Due to the fast polymerization kinetics of the LAP photoinitiator, the crosslinking time can be reduced to 30 s; however, 1 min crosslinking time is suggested to ensure maximum PEG-RGDS conjugation to the PEG-PQ matrix. 6 Fill 1 well of a 6-well plate with cell culture media. Using sterile tweezers, carefully pick up each hydrogel droplet and transfer to the media in the well plate. 7 Maintain cell-laden hydrogels in culture changing media every 4 days or as necessary.
Note: Cell-laden hydrogels can be maintained for at least 15 days in culture for quantification of cellular metrics.
Characterization of PEG-RGDS incorporation
This protocol describes a method to quantify the concentration of PEG-RGDS that is incorporated into the hydrogel during the photocrosslinking process. Particularly, the increase in incorporation efficiency of PEG-RGDS in the presence of the NVP co-monomer is demonstrated. PEG-RGDS is mixed with ratiometric concentration of fluorescently labeled PEG-RGDS-Alexa Fluor 1 488 and the fluorescence images of the hydrogel precursor prior to crosslinking, immediately after crosslinking (to account for photobleaching), and after overnight rinsing (to remove unconjugated moieties) is acquired. Fluorescence intensities are quantified via FIJI to obtain the final incorporation efficiency. 1 Mix PDMS base elastomer and curing agent in the ratio of 10:1 on a weighing scale and degasify using a vacuum chamber.
Materials
2 Cure a thin (500 mm) sheet of PDMS at 70 C between two clean glass slides fitted with 500 mm thick shims as spacers. 3 Punch 3 mm diameter holes in the PDMS sheet using the biopsy punch to make PDMS molds. 4 Prepare PEG-PQ, PEG-RGDS, NVP and LAP stock in PBS as described in the previous section.
5 Prepare PEG-RGDS-488 stock in PBS (10 mM) (68 mg/mL or 6.8 mg/100 mL). 6 For preparation of the final solution, the total RGDS concentration (PEG-RGDS + PEG-RGDS-488)
should be kept constant at 1, 5, or 10 mM. The final concentration of PEG-RGDS-488 should be constant at 0.5 mM; adjust the PEG-RGDS concentration accordingly to 0.5, 4.5, or 9.5 mM. 7 Prepare final precursor with PEG-PQ = 5 % w/v, PEG-RGDS = 1, 5, or 10 mM, LAP = 3 mg/mL and NVP = 0, 0.5, 1, or 2 mL/mL and adjust with PBS. Mix all components thoroughly. 8 Fix PDMS molds on glass a coverslip and pipet 3 mL of precursor solution into the molds.
9 On the microscope and camera, pre-set exposure time (100 ms) and excitation intensity (20 mW/ cm 2 ) settings. Set the coverslip with precursor solution on the microscope stage and image precursor solution using a GFP filter cube (excitation: 450À490 nm, emission: 500À550 nm). Note: Keep intensity and exposure settings constant throughout the entire experiment.
Note: Acquire images 200 mm from the bottom of the coverslip to ensure imaging at the same zlocation in all samples. Note: Acquisition settings will vary between microscopes. Adjust the excitation intensity and acquisition time as needed. 10 Remove the coverslip from the stage and photocrosslink the polymer precursor solution under the UV lamp for 1 min. 11 Without removing the PDMS mold, re-image the crosslinked hydrogel again using the same acquisition settings. Note: Comparing fluorescence intensities of the images from the un-crosslinked precursor solution and immediately post-crosslinking will provide the ability to quantify the amount of photobleaching and to correct for it. 12 Remove the PDMS mold, transfer the hydrogels to well plates with PBS buffer and incubate overnight at room temperature to remove un-crosslinked moieties. 13 Transfer the hydrogels to coverslips, add a few drops of PBS, and re-image using the same microscope settings. Note: Comparing the fluorescence intensities of images immediately post-crosslinking and after overnight rinsing will give the relative percentage of RGDS conjugated in the final hydrogels. 14 Analyze images using FIJI software (NIH, Version 1.52h) to quantify fluorescence intensities (Fig. 2) .
Quantify The following assumptions are made to quantify the conjugation efficiency using this approach:
1 PEG-RGDS and PEG-RGDS-488 have the same incorporation efficiency (no competitive behavior).
2 The molecular weights of PEG-RGDS and PEG-RGDS-488 are similar (based on molar ratios used during synthesis). 3 Overnight rinsing ensures complete removal of unconjugated moieties.
The following equations are used to quantify the concentration of conjugated PEG-RGDS in the hydrogels:
where I 0 is the fluorescence intensity prior to crosslinking and I 1 is the fluorescence intensity immediately after crosslinking which accounts for bleaching.
where I 2 is the fluorescence intensity after rinsing and removal of unconjugated moieties.
where R is the initial PEG-RGDS concentration in the prepolymer solution (R = 1, 5 or 10 mM PEG-RGDS).
Characterization of hydrogel elasticity
This protocol describes a method to quantify the compressive modulus of hydrogels, in particular, the changes in compressive modulus resulting from increased NVP co-monomer concentration (increased crosslink density) in PEG-PQ hydrogels. Of note in this assay is the fact that, incorporation of PEG-RGDS was not deemed necessary in the hydrogel formulation as the presence of cell-adhesive ligands has been demonstrated to have negligible effect on the bulk modulus of the hydrogels [13] . (1)- (3) are used to quantify the incorporation efficiency and incorporated PEG-RGDS concentration from the measured intensities.
1 Prepare PDMS containing 3 mm diameter holes and a thickness of 1 mm as per previous instructions. 2 Prepare the precursor solution with PEG-PQ = 5 % w/v, PEG-RGDS = 1 mM, LAP = 3 mg/mL and NVP = 0, 0.5, 1, or 2 mL/mL in PBS.
Note: PEG-RGDS is necessary only when encapsulating cells. When making acellular gels, PEG-RGDS can be omitted if desired.
3 Pipet 15 mL of precursor solution or precursor with MDA-MB-231 (10*10 6 cells/mL) into PDMS molds affixed on a glass slide. 4 Photocrosslink under the UV lamp for 1 min. 5 Transfer acellular hydrogels to a well-plate with PBS and incubate overnight to achieve equilibrium swelling. If encapsulating cells, transfer hydrogels to a well plate with cell culture media and incubate for 1-15 days as desired. Note: Acellular hydrogels can be tested on day 1 post-crosslinking. Cell-laden hydrogels can be tested either on day 1 to characterize the initial elasticity or at some later time point (day 15 for example) to characterize elasticity after cell-mediated hydrogel degradation. 6 On the Instron system, set up the unconfined compression system with platens and a liquid bath chamber filled with warm PBS (Fig. 3) .
Note: Use a 10 N load cell with a compression rate of 2 mm/s for 100 s with an initial load of 0.02 N to ensure uniform contact between the hydrogel and compression plates. 7 Measure the hydrogel thickness and diameter prior to loading and hydrogel diameter at the end of the compression cycle using calipers. 8 Load hydrogel samples between parallel plates and proceed with compression testing to obtain force vs. displacement measurements. Note: Avoid cracking or fracturing of the hydrogel under compression. If necessary, reduce the compression rate or maximum compression value.
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Fig . 3 . Schematic of mechanical testing system. An Instron compression testing system is used to measure compressive moduli of hydrogels. The hydrogel sample is placed in between parallel plates surrounded by a PBS chamber and undergoes unconfined compression as controlled by the load cell and z-height controller.
9 Obtain stress vs. strain values and calculate the slope of a linear fit (within the first 20 % of the strain compression) to determine the compressive modulus (Fig. 4) . 
Characterization of hydrogel swelling
This protocol describes a method to quantify the swelling ratio of hydrogels, especially, the reduction in swelling ratio with increased NVP concentration (increased crosslink density). 1 Prepare the polymer precursor solution with PEG-PQ = 5 % w/v, LAP = 3 mg/mL, and NVP = 0, 0.5, 1, or 2 mL/mL in PBS. 2 Pipet 15 mL of precursor solution into PDMS molds affixed on a glass slide and photocrosslink under UV lamp for 1 min. 3 Transfer hydrogels to a well-plate with PBS and incubate overnight to achieve equilibrium swelling. 4 Weigh swollen hydrogels on a carefully tared balance.
Note: Wick off excess PBS from hydrogels using a Kimwipe prior to weighing. 5 Allow the hydrogels to dry in ambient air for 6 h. 6 Weigh the dried hydrogels. 7 Calculate the swelling ratio using the equation below (Fig. 5) :
Characterization of hydrogel degradation
This protocol describes a method to quantify changes in the hydrogel degradability, especially, due to incorporation of the non-degradable NVP co-monomer in the hydrogel. Methacryloxyethyl thiocarbamoyl rhodamine B (containing free acrylate end groups) is conjugated to the PEG-PQ hydrogel matrix at low concentrations, thereby fluorescently labeling the hydrogels. The reduction in fluorescence intensity of hydrogels under the action of collagenase IV is monitored over time to quantify the rate of degradation of hydrogels.
In particular, this protocol helps quantify the inherent degradability of hydrogel matrices under the action of a digesting enzyme and not the ability of cells to degrade the hydrogel matrix. Encapsulated cells may have varying MMP profiles and secretion rates depending on matrix conditions, which would make it difficult to account for cell-induced matrix degradation. 5 Prepare collagenase IV solution in PBS to a final concentration of 100 mg/mL and warm to 37 C in a water bath. 6 Transfer the swollen hydrogels to 96 well plates with PBS (1 hydrogel/well) and incubate at 37 C for 30 min. 7 Image hydrogels using rhodamine filter cube (excitation: 538À562 nm, emission: 570À640 nm)
with an excitation intensity of 27 mW/cm 2 and acquisition time of 100 ms.
Note: Acquisition settings will vary between microscopes. Adjust the excitation intensity and acquisition time as needed. 8 Replace the PBS buffer with warm collagenase solution. 9 Acquire fluorescence images every 15 min.
Note: Make sure that collagenase buffer stays warm; either use a heated incubation stage or return to 37 C incubator between imaging cycles. Note: Include a control group: PEG-PQ hydrogel with only PBS buffer (no collagenase) to serve as reference to account for any photobleaching that may occur during image acquisition. 10 Analyze the images using FIJI software to quantify fluorescence intensities (Fig. 6) .
Characterization of hydrogel mesh size
This protocol describes a method to quantify changes in the hydrogel mesh size, especially, due to incorporation of additional NVP (leading to additional crosslink density and reduced porosity) in the hydrogel matrix. 4 Dissolve FITC-dextran in DI water at 1 mg/mL. Filter the solution through a 0.22 mm filter to remove particulates. 5 Remove PBS and add FITC-dextran to the hydrogels; incubate at 4 C for 48 h. 6 Post-incubation, transfer the dextran-swollen hydrogels into a 96-well plate and blot off excess dextran with a Kimwipe.
7 Add 200 mL of DI water to each well and collect 50 mL of solution from the well every 15 min and pipet it into a new 96-well plate. 8 Analyze the fluorescence intensity of the collected solutions in the new well plate (Excitation: 490 nm, Emission: 525 nm) using a plate reader.
9 Add 50 mL of DI water to each hydrogel sample after each collection time point to compensate for the collected solution. Vortex well plate momentarily to homogenously distribute diffused dextran within each well plate. 10 Continue collection for $4 h or until no significant change in fluorescence intensity is observed. 11 Tabulate the quantified fluorescence intensities and subtract background fluorescence intensity measured at the 0 min time point to obtain corrected average intensities for each time point.
[ ( F i g . _ 6 ) T D $ F I G ] The cumulative mass of FITC-dextran released is analyzed from the measured fluorescence intensities and used to calculate the diffusion coefficient of FITC-dextran in the hydrogel according to the equation below [14] :
where M t is the mass of released FITC-dextran at time t, M 1 is the cumulative mass of FITC-dextran, M t /M 1 is the fractional mass of FITC-dextran released, D is the effective diffusion coefficient, and 2d is the hydrogel thickness (500 mm).
The theoretical mesh size of the hydrogels is estimated using the hindered solute diffusion in solvent-filled-pores model based on the following equation (Fig. 7) :
where D is the effective diffusion coefficient of 150 kDa FITC-dextran in hydrogels, D 0 is the diffusion coefficient of 150 kDa FITC-dextran calculated from the Stokes-Einstein's equation (2.09 Â 10 À7 cm 2 / s), and l is a characteristic ratio of the FITC-dextran hydrodynamic diameter to the average pore diameter of the hydrogel matrix. The Stokes' radii and hydrodynamic diameter of 150 kDa dextran was estimated to be 8.5 nm and 17 nm respectively, as provided by the manufacturer.
Quantification of cell viability
This protocol describes an assay to quantify cell viability and viable cell density within PEG-based hydrogels post 3D encapsulation using a standard cell viability kit and image analysis. Changes in these metrics over time form the basis for subsequent classification of cancer cell phenotype within engineered hydrogel formulations. 1 Add 1 mL of warm PBS into 1 well of a 24-well plate. Using sterile tweezers, transfer each cell-laden hydrogel from the culture media to the warm PBS. Incubate for 5 min at room temperature to remove media. 2 Replace with fresh warm PBS again and incubate for additional 5À10 min.
Note: As media inside the hydrogel diffuses into the surrounding PBS, hydrogels will change color from pink to whitish. 3 Prepare the staining solution in warm PBS according to manufacturer's recommended concentration. 4 Remove the PBS and add the staining solution to the hydrogels. Incubate in dark for 20À30 min at room temperature. 5 Remove the staining solution and add fresh PBS to remove excess staining solution. Incubate for 10 min at room temperature. 6 Remove PBS and replace with fresh PBS. 7 Prepare imaging setup (Fig. 8A): a Clean 2 glass coverslips and PDMS molds with ethanol. Attach the mold to one coverslip and squeeze out trapped air bubbles using tweezers. b Add a drop of PBS into each of the punched holes in the PDMS molds. c Using tweezers, transfer each hydrogel sample into a punched PDMS mold. d Add a 2nd coverslip on top of the PDMS mold to make a sandwich-like setup.
Note: Make sure all holes are completely filled with PBS and there are no air bubbles trapped between the coverslips adjoining the hydrogels as fluorescence signal can get distorted during imaging. 8 Transfer the hydrogel-PDMS mold setup onto the microscope stage. 9 In acquisition settings, choose GFP (excitation: 450À490 nm, emission: 500, 550 nm) and rhodamine (excitation: 538À562 nm, emission: 570À640 nm) channels. Optimize exposure time and excitation intensity based on fluorescence intensity of stained samples.
10 Acquire z-stacks (z-height: $150 mm, step size: 3 mm) (Fig. 8B) .
Note: Complete imaging within 1À2 h of staining. Stained samples can be stored for 2À3 h in PBS at room temperature. Note: The hydrogel-PDMS mold setup can be flipped to acquire z-stacks from the opposite side of the hydrogel and to acquire images from a larger volume if desired (Fig. 8A) . 11 Analyze the z-stacks using FIJI or other image analysis software to quantify the number of live cells, dead cells, and cell density per unit volume. Calculate the percent viability and viable cell density. 
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Quantification of early apoptosis
This protocol describes an assay to quantify early apoptosis of cells cultured within PEG-based hydrogels via fluorescent immunolabeling and quantification of Annexin V. This assay is necessary to demonstrate that encapsulated cells that undergo death, do so via spontaneous apoptotic process, and not due to nutrient limitations, hypoxia, or necrosis. Note: Positive Annexin V staining should follow an approximate circular appearance (around the cell membrane). Note: The hydrogel-PDMS mold setup can be flipped to acquire z-stacks from the opposite side of the hydrogel and to acquire a larger volume as described earlier.
Note: For a positive control, incubate cell-laden hydrogels with 1 mg/mL Staurosporine. From the stock solution at 1 mg/mL, dilute 1:1000 in culture media and add to cell-laden hydrogels for 1 h at 37 C and 5 % CO 2 . Remove the media and proceed with above steps. 9 Analyze z-stacks using FIJI or other image analysis software to quantify the percentage of Annexin V positive cells. Note: When using FIJI, the manual counting method is preferred to obtain accurate cell counts. Load the z-stack in FIJI and use the following code to improve the z-stack for manual quantification: run("Subtract Background . . . ", "rolling = 50"); run("Enhance Contrast", "saturated = 0.35"); Using the multi-point tool, click on individual cells and mark them as they are counted. Keep the marks on the counted cells visible throughout the process. Progress through each plane of the zstack and ensure same cells are not counted more than once. Note the total number of cells counted at the end.
Quantification of cell proliferation
This protocol describes an assay to quantify cell proliferation within PEG-based hydrogels via fluorescent labeling of EdU incorporated in the nuclei of dividing cells. The results of this assay provide another metric for quantification of cell phenotypes. 3 Using tweezers, transfer cell-laden hydrogels into a separate 24-well plate. Incubate with EdU working solution at 37 C for 24 h. Note: The incubation time can be varied depending on the experimental condition and cell doubling time. 4 After 24 h, remove media and rinse hydrogels twice with warm PBS for 10 min each rinse to completely remove media. 5 Add 4 % paraformaldehyde to hydrogels and incubate at room temperature for 30 min.
[ ( F i g . _ 9 ) T D $ F I G ] Note: Fixed samples can be stored at 4 C for a few days. 7 Add PBS-T to hydrogels and incubate at room temperature for 30 min. 8 Remove PBS-T, add blocking buffer to hydrogels, and incubate for 30 min; else samples can be stored for a few days at this step. 9 Prepare Click-It reaction cocktail as below:
a For a total volume of 1 mL of reaction cocktail, dilute 10X buffer additive in DI water to 1X (10 mL 10X stock +90 mL of DI water).
Note: Prepare 1X buffer additive fresh each time within 1 h of assay, do not store.
b To 1X reaction buffer (86 mL 10X stock +774 mL DI water), add copper sulfate solution: 40 mL,
Alexa Fluor
1 568 picolyl azide: 1 mL, 1X buffer additive and mix well.
Note: The choice of fluorophore for labeling incorporated EdU can be chosen by the user. 10 Remove blocking buffer from hydrogels and add this reaction cocktail to the hydrogels. Incubate at room temperature for 2 h, protected from light. 11 Remove the cocktail from the hydrogels and rinse twice with PBS-T (5 min each).
12 Prepare Hoechst working solution (10 mL/mL in blocking buffer) and add to the hydrogels. Incubate at room temperature for 15 min. 13 Rinse with PBS twice to remove excess Hoechst. 14 Load the hydrogels with PBS under glass coverslips and punched PDMS molds (as described earlier). 15 Acquire fluorescent z-stacks of hydrogels on a confocal or structured illumination microscope. For Alexa Fluor 1 568, use the rhodamine channel (excitation: 538À562 nm, emission: 570À640 nm). For Hoechst, use the DAPI channel (excitation: 330À370 nm, emission: 430À480 nm). Optimize the acquisition time and excitation intensity based on the fluorescence intensity of labeled samples (z-height: $150 mm, step size: 3 mm) (Fig. 10) . Note: Manual quantification of cell proliferation is preferred as described above in the early apoptosis assay. After background subtraction and contrast enhancement of the z-stack, use the multi-point tool to mark each cell plane-by-plane taking care not to mark each cell twice. At the end of the last plane, note the total number of marked cells to obtain the cell number.
Quantification of metabolic activity
This protocol describes an assay to quantify metabolic activity of cells cultured within PEG-based hydrogels using an Alamar Blue assay. Though this assay does not differentiate between distinct modes of metabolism (glycolysis vs. oxidative phosphorylation), it serves as an important metric for phenotypic classification. 5 Add the working solution to the hydrogels (100 mL/well) and incubate for 4 h at 37 C. Note: At the end of the incubation period, there should be a color change from bluish to reddish/ pinkish. Incubation time can be varied based on the metabolic activity of the cells and the sensitivity of the plate reader. Incubation time can be increased to 8 h if the cells have very low metabolism. 6 Transfer the hydrogels to a new 96-well plate with phenol-red-free media using tweezers. In the same well plate, include 2 controls: (1) phenol-red-free media without hydrogels or Alamar blue reagent and (2) hydrogels in phenol-red-free media without Alamar blue reagent. 7 Use a plate reader to measure the fluorescence intensity (Excitation: 550 nm, Emission: 600 nm).
Subtract readings from unstained hydrogels to remove background noise. 8 Display results either as absolute values or normalized to day 0 control values.
Note: The normalized metabolic activity can be divided by the viable cell density for each hydrogel formulation and each time point to obtain a cellular metabolic activity (activity on a per cell basis), which can then be compared across groups.
Quantification of single cells and cell cluster properties
This protocol describes an assay and image analysis techniques to quantify metrics related to 3D morphology of encapsulated cells and cell clusters. This quantification provides direct visual evidence of cluster formation from single encapsulated cells over time, invasiveness of single cells and resulting clusters, and relative density of cells/clusters within the 3D hydrogel matrix. Note: Fixed samples can be stored at 4 C for a few days. 5 Add PBS-T to hydrogels and incubate at room temperature for 30 min. 6 Remove PBS-T, add blocking buffer to hydrogels, and incubate for 30 min. 7 Prepare Alexa Fluor 1 568 Phalloidin in blocking buffer (25 mL/mL).
8 Remove blocking buffer from hydrogels and add Phalloidin stain. Incubate for 30 min at room temperature.
9 Remove Phalloidin stain and add Hoechst working solution (10 mL/mL in blocking buffer). Incubate for 10 min at room temperature. 10 Rinse twice with PBS (10 min each). 11 Load hydrogels with PBS under glass coverslips and punched PDMS molds (as described earlier). 12 Acquire fluorescent z-stacks of hydrogels on confocal microscope. For Alexa Fluor 1 568, use the rhodamine channel (excitation: 538À562 nm, emission: 570, 640 nm). For Hoechst, use the DAPI channel (excitation: 330À370 nm, emission: 430À480 nm). Optimize image acquisition settings based on fluorescence intensity of labeled samples (z-height: $150 mm, step size: 3 mm) (Fig. 11) .
Note: The hydrogel-PDMS mold setup can be flipped to acquire z-stacks from the both sides of the hydrogel and to capture a larger volume as described earlier.
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Classification of cell states and phenotypic dormancy metrics
This method describes the analytical steps to classify hydrogel formulations, based on quantified cellular metrics, into groups that support specific cancer states: (1) high growth, (2) moderate growth, (3) single cell, restricted survival dormancy, and (4) balanced dormancy. A multitude of metrics can be used to quantify cell phenotype but this approach relies on temporal changes in live cell density, dead cell density, and metabolic activity as the basis for classification. 
Reactivation of dormant tumor cells
This protocol describes a method to reactivate single dormant cancer cells toward an invasive, proliferative state that is reminiscent of metastatic recurrence. This phenotypic switch is induced via a dynamic increase in ligand density in long-term culture, which is simulative of dormant single cells experiencing increased matrix adhesivity with deposition of cell-permissive extracellular matrix components in the native dormant niche. 2 Prepare PEG-RGDS stock in PBS (20 mM) (68 mg/mL or 6.8 mg/100 mL).
4 Prepare final polymer precursor solution with PEG-PQ = 5 % w/v and LAP = 3 mg/mL and adjust with PBS. Mix all components thoroughly. 5 Encapsulate cells in this hydrogel formulation at 10 million cells/mL as described earlier and maintain in culture for 40 days. Replace media every 4 days. 6 Conduct quantification of cell viability, viable cell density, and proliferation on 0, 15, and 30 days post encapsulation as per above protocols. 7 On day 40, prepare an RGDS precursor solution with a final concentration of PEG-RGDS = 10 mM and LAP = 3 mg/mL in PBS. Mix thoroughly. 8 Using tweezers, transfer cell-laden hydrogels into a microcentrifuge tube filled with PBS. Rinse twice in PBS for 10 min each to completely remove media. 9 Remove PBS and add the PEG-RGDS/LAP precursor solution to the hydrogels. Incubate at 37 C for 1 h to allow diffusion of PEG-RGDS into the hydrogel. 10 Warm up the UV lamp. Transfer the hydrogels from a microcentrifuge tube to a Parafilm covered glass slide. Photocrosslink for 1 min. 11 Transfer the PEG-RGDS crosslinked hydrogels into a well plate with culture media and maintain in culture for an additional 35 days. 12 Conduct quantification of cell viability, viable cell density, and proliferation on 5, 15, and 35 days post PEG-RGDS coupling (See Fig. 7 in Ref. [7] ).
Conclusions
We presented protocols and methods pertaining to fabrication of PEG-based hydrogels with welldefined and well-controlled physical and biochemical properties and 3D culture of MDA-MB-231 cells for the investigation of tumor dormancy and metastatic recurrence. We also described methods of quantifying cellular metrics of 3D cultured cells and implementing these metrics to phenotypically classify hydrogel formulations into groups that support specific cancer cell states. The systematic phenotypic classification of hydrogel formulations provides a roadmap toward designing engineered matrices for regulating cell fates for various applications, including tumor dormancy and metastasis. We also described the method for dynamically increasing ligand density in cell-laden hydrogels (via incorporation of PEG-RGDS) to induce reactivation of single dormant tumor cells into invasive proliferative populations, reminiscent of metastatic recurrence. These methods will potentially be useful for mechanistic investigations of tumor dormancy, not only for MDA-MB-231 cells, but also other breast cancer cell lines and other cancer types. In the future, this engineered in vitro platform could potentially aid in discovery and development of dormancy-associated molecular targets and drugs toward those targets.
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